6α-Fluoroprednisolone acetate

CAS: 570-36-5

Ref. 3D-FF102549

Información del producto

• Nombre: 6α-Fluoroprednisolone acetate
• Sinónimos: (6Alpha,11Beta)-6-Fluoro-11,17-Dihydroxy-3,20-Dioxopregna-1,4-Dien-21-Yl Acetate, 21-Acetoxy-6α-fluoro-11β,17-dihydroxypregna-1,4-diene-3,20-dione, 6alpha-Fluoro-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 21-acetate, 6alpha-Fluoroprednisolone Acetate, 6α-Fluoroprednisolone-21-acetate, Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-6-fluoro-11,17-dihydroxy-, (6α,11β)-, Pregna-1,4-diene-3,20-dione, 6α-fluoro-11β,17,21-trihydroxy-, 21-acetate

Descripción

6alpha-Fluoroprednisolone acetate is a corticosteroid that is used for the treatment of inflammatory diseases. It has a high therapeutic index and does not bind to mineralocorticoid receptors in the body. 6alpha-Fluoroprednisolone acetate is administered as an aerosol or a microsphere. It can be used in cell culture because it does not inhibit protein synthesis or cause morphological changes to cells. The drug has been shown to have a low cytotoxicity profile, which may be due to its ability to suppress pd-l1 and Mcl-1 proteins, which are associated with cancer metastasis. Clinical data suggests that 6alpha-fluoroprednisolone acetate has no adverse effects on the liver, kidney, or bone marrow.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 420.47 g/mol
• Fórmula: C₂₃H₂₉FO₆
• Pureza: Min. 95%